At the cellular level, statins primarily target hepatocytes (liver cells) where cholesterol synthesis occurs. By blocking HMG-CoA reductase, statins reduce the intracellular concentration of cholesterol, leading to upregulation of LDL receptors on the cell surface. This results in increased uptake of LDL particles from the bloodstream, lowering blood cholesterol levels.
